Rating History for Talecris Biotherapeutics (TLCR) by Capstone Investments
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/29/2010 | N/A | Upgrade | Buy (N/A) |
N/A (N/A) |
22.05 (28.80) |
30.61% | Details |
 |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/29/2010 | N/A | Upgrade | Buy (N/A) |
N/A (N/A) |
22.05 (28.80) |
30.61% | Details |
|
|||||||
